IntelGenx Corp (OTCMKTS:IGXT) Stock Surges 85% YTD: Here is Why
Yesterday IntelGenx Corp (OTCMKTS:IGXT) announced that it signed definitive supple and licensing agreement with an unnamed licensed men’s health firm for two products that it is working on. The agreement is connected to the commercialisation and co-development of the Tadalafil oral films that is meant for treating erectile dysfunction and benign prostatic hyperplasia (BPH). The company is working on the development of the product with Aquestive Therapeutics Inc. The announcement…